Altered signaling in systemic juvenile idiopathic arthritis monocytes

被引:17
|
作者
Macaubas, Claudia [1 ]
Wong, Elizabeth [1 ]
Zhang, Yujuan [1 ,6 ]
Nguyen, Khoa D. [1 ]
Lee, Justin [1 ]
Milojevic, Diana [2 ,6 ]
Shenoi, Susan [3 ,4 ]
Stevens, Anne M. [3 ,4 ]
Ilowite, Norman [5 ]
Saper, Vivian [1 ]
Lee, Tzielan [1 ]
Mellins, Elizabeth D. [1 ]
机构
[1] Stanford Univ, Dept Pediat, Program Immunol, Stanford, CA 94305 USA
[2] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
[3] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA
[4] Univ Washington, Sch Med, Seattle, WA USA
[5] Albert Einstein Coll Med, Childrens Hosp Montefiore, Bronx, NY 10467 USA
[6] Tufts Univ, Sch Med, Dept Pediat, Boston, MA 02111 USA
基金
美国国家卫生研究院;
关键词
Juvenile arthritis; Monocytes; IFN signaling; SOCS1; GENE-EXPRESSION PROFILES; PLACEBO-CONTROLLED TRIAL; INTERFERON-GAMMA; ALTERNATIVE ACTIVATION; MACROPHAGE ACTIVATION; PERIPHERAL-BLOOD; DOUBLE-BLIND; SINGLE-CELL; IFN-GAMMA; SUPPRESSOR;
D O I
10.1016/j.clim.2015.12.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation anti arthritis. Monocytes are implicated in sJIA pathogenesis, but their role in disease is unclear. The response of sJIA monocytes to IFN may be dysregulated. We examined intracellular signaling in response to IFN type I (IFN alpha) and type II (IFN gamma) in monocytes during sJIA activity and quiescence, in 2 patient groups. Independent of disease activity, monocytes from Group 1 (collected between 2002 and 2009) showed defective STAT1 phosphorylation downstream of IFNs, and expressed higher transcript levels of SOCS1, an, inhibitor of IFN signaling. In the Group 2 (collected between 2011 and 2014), monocytes of patients with recent disease onset were IFN gamma hyporesponsive, but in treated, quiescent subjects, monocytes were hyperresponsive to IFN gamma. Recent changes in medication in sJIA may alter the IFN hyporesponsiveness. Impaired IFN/pSTAT1 signaling is consistent with skewing of sJIA monocytes away from an M1 phenotype and may contribute to disease Pathology. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 50 条
  • [31] Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis
    Nigrovic, Peter A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (52) : 15785 - 15786
  • [32] MEFV mutations in Systemic Juvenile Idiopathic Arthritis
    Aktay, Ayaz N.
    Bilginer, Y.
    Yilmaz, E.
    Erguven, M.
    Besbas, N.
    Topaloglu, R.
    Bakkaloglu, A.
    Ozen, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 217 - 217
  • [33] Thalidomide for systemic onset juvenile idiopathic arthritis
    K. Sathe
    Raju P. Khubchandani
    Indian Pediatrics, 2013, 50 : 237 - 239
  • [34] Biologic therapies in systemic juvenile idiopathic arthritis
    Batu, Ezgi Deniz
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 621 - 629
  • [35] Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management
    Sathish Kumar
    The Indian Journal of Pediatrics, 2016, 83 : 322 - 327
  • [36] Canakinumab for the treatment of systemic juvenile idiopathic arthritis
    Grom, Alexei A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (11) : 1427 - 1435
  • [37] JAK inhibitors in systemic juvenile idiopathic arthritis
    He, Tingyan
    Xia, Yu
    Luo, Ying
    Yang, Jun
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [38] Tapering canakinumab in systemic juvenile idiopathic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (10): : E593 - E593
  • [39] Extracellular vesicles in systemic juvenile idiopathic arthritis
    Maller, Justine
    Morgan, Terry
    Morita, Mayu
    McCarthy, Frank
    Jung, Yunshin
    Svensson, Katrin J.
    Elias, Joshua E.
    Macaubas, Claudia
    Mellins, Elizabeth
    JOURNAL OF LEUKOCYTE BIOLOGY, 2023, 114 (05) : 387 - 403
  • [40] Canakinumab (Ilaris) for Systemic Juvenile Idiopathic Arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1423): : 65 - 66